Stock TCON TRACON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News TRACON Pharmaceuticals, Inc.

Equities

TCON

US89237H3084

Real-time Estimate Cboe BZX
Other stock markets
 03:15:32 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.135 USD -3.81% Intraday chart for TRACON Pharmaceuticals, Inc. -12.50% -68.02%
May. 14 TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 14 Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024
Tracon: Q1 Earnings Snapshot
AQ
Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000
MT
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Tracon Pharmaceuticals, Inc. Appoints David Lazar as Chief Business Development Officer
CI
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
AQ
TRACON Pharmaceuticals Announces Reverse Stock Split
AQ
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
AQ
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
CI
HC Wainwright Adjusts Price Target on TRACON Pharmaceuticals to $6 From $7, Keeps Buy Rating
MT
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tracon: Q4 Earnings Snapshot
AQ
Transcript : TRACON Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 05, 2024
Earnings Flash (TCON) TRACON PHARMACEUTICALS Reports Q4 Revenue $3M, vs. Street Est of $1.5M
MT
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
AQ
TRACON Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
AQ
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
AQ
TRACON Pharmaceuticals, Inc. Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TCON Stock
  4. News TRACON Pharmaceuticals, Inc.